Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

M Hugh Cole

Affiliations

  • Chief Business Officer at Jounce Therapeutics Inc. (JNCE), 2019-08-17
  • Director at Catabasis Pharmaceuticals Inc (CATB), 2019-07-30
  • Svp, Chief Business Officer at Ariad Pharmaceuticals Inc (ARIA), 2017-02-16
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
JNCE $7.84 1,900 Officer 1,900 2018-06-15 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
JNCE $3.92 1,018 Officer 36,214 2019-08-16 Filing
JNCE $4.00 648 Officer 37,232 2019-08-15 Filing
JNCE $4.10 670 Officer 37,880 2019-08-14 Filing
ARIA $7.05 6,012 Officer 29,916 2016-06-28 Filing